241 related articles for article (PubMed ID: 35462463)
1. Current status of cancer starvation therapy.
Li J; Tong D; Lin J
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 51(2):241-250. PubMed ID: 35462463
[TBL] [Abstract][Full Text] [Related]
2. Metabolic effects of anti-angiogenic therapy in tumors.
Zulato E; Curtarello M; Nardo G; Indraccolo S
Biochimie; 2012 Apr; 94(4):925-31. PubMed ID: 22245704
[TBL] [Abstract][Full Text] [Related]
3. Anti-Angiogenics: Current Situation and Future Perspectives.
Zirlik K; Duyster J
Oncol Res Treat; 2018; 41(4):166-171. PubMed ID: 29562226
[TBL] [Abstract][Full Text] [Related]
4. Evading tumor evasion: current concepts and perspectives of anti-angiogenic cancer therapy.
Abdollahi A; Folkman J
Drug Resist Updat; 2010; 13(1-2):16-28. PubMed ID: 20061178
[TBL] [Abstract][Full Text] [Related]
5. Broad targeting of angiogenesis for cancer prevention and therapy.
Wang Z; Dabrosin C; Yin X; Fuster MM; Arreola A; Rathmell WK; Generali D; Nagaraju GP; El-Rayes B; Ribatti D; Chen YC; Honoki K; Fujii H; Georgakilas AG; Nowsheen S; Amedei A; Niccolai E; Amin A; Ashraf SS; Helferich B; Yang X; Guha G; Bhakta D; Ciriolo MR; Aquilano K; Chen S; Halicka D; Mohammed SI; Azmi AS; Bilsland A; Keith WN; Jensen LD
Semin Cancer Biol; 2015 Dec; 35 Suppl(Suppl):S224-S243. PubMed ID: 25600295
[TBL] [Abstract][Full Text] [Related]
6. Targeted therapies of cancer: angiogenesis inhibition seems not enough.
Roodink I; Leenders WP
Cancer Lett; 2010 Dec; 299(1):1-10. PubMed ID: 20889254
[TBL] [Abstract][Full Text] [Related]
7. Molecular regulation of tumor angiogenesis: mechanisms and therapeutic implications.
Harper J; Moses MA
EXS; 2006; (96):223-68. PubMed ID: 16383021
[TBL] [Abstract][Full Text] [Related]
8. Growing tumor vessels: more than one way to skin a cat - implications for angiogenesis targeted cancer therapies.
Leite de Oliveira R; Hamm A; Mazzone M
Mol Aspects Med; 2011 Apr; 32(2):71-87. PubMed ID: 21540050
[TBL] [Abstract][Full Text] [Related]
9. Clinical approaches toward tumor angiogenesis: past, present and future.
Fujita Y; Abe R; Shimizu H
Curr Pharm Des; 2008; 14(36):3820-34. PubMed ID: 19128235
[TBL] [Abstract][Full Text] [Related]
10. Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.
Zhao Y; Adjei AA
Oncologist; 2015 Jun; 20(6):660-73. PubMed ID: 26001391
[TBL] [Abstract][Full Text] [Related]
11. Oncogenes and tumor angiogenesis: the question of vascular "supply" and vascular "demand".
Rak J; Yu JL
Semin Cancer Biol; 2004 Apr; 14(2):93-104. PubMed ID: 15018893
[TBL] [Abstract][Full Text] [Related]
12. Anti-angiogenic treatment strategies for malignant brain tumors.
Kirsch M; Schackert G; Black PM
J Neurooncol; 2000; 50(1-2):149-63. PubMed ID: 11245274
[TBL] [Abstract][Full Text] [Related]
13. Anti-angiogenic cancer therapy based on integrin alphavbeta3 antagonism.
Cai W; Chen X
Anticancer Agents Med Chem; 2006 Sep; 6(5):407-28. PubMed ID: 17017851
[TBL] [Abstract][Full Text] [Related]
14. Tumor vasculature: the Achilles' heel of cancer?
Johannessen TC; Wagner M; Straume O; Bjerkvig R; Eikesdal HP
Expert Opin Ther Targets; 2013 Jan; 17(1):7-20. PubMed ID: 23121690
[TBL] [Abstract][Full Text] [Related]
15. Vascular disrupting agents in cancer therapy.
Smolarczyk R; Czapla J; Jarosz-Biej M; Czerwinski K; CichoĊ T
Eur J Pharmacol; 2021 Jan; 891():173692. PubMed ID: 33130277
[TBL] [Abstract][Full Text] [Related]
16. Targeting endothelial cell metabolism in cancerous microenvironment: a new approach for anti-angiogenic therapy.
Mohammadi P; Yarani R; Rahimpour A; Ranjbarnejad F; Mendes Lopes de Melo J; Mansouri K
Drug Metab Rev; 2022 Nov; 54(4):386-400. PubMed ID: 36031813
[TBL] [Abstract][Full Text] [Related]
17. New advances in the research of clinical treatment and novel anticancer agents in tumor angiogenesis.
Li X; Zhou J; Wang X; Li C; Ma Z; Wan Q; Peng F
Biomed Pharmacother; 2023 Jul; 163():114806. PubMed ID: 37163782
[TBL] [Abstract][Full Text] [Related]
18. Potential Role of Natural Compounds as Anti-Angiogenic Agents in Cancer.
Shanmugam MK; Warrier S; Kumar AP; Sethi G; Arfuso F
Curr Vasc Pharmacol; 2017; 15(6):503-519. PubMed ID: 28707601
[TBL] [Abstract][Full Text] [Related]
19. Current progress in antivascular tumor therapy.
Ho YJ; Wang TC; Fan CH; Yeh CK
Drug Discov Today; 2017 Oct; 22(10):1503-1515. PubMed ID: 28625610
[TBL] [Abstract][Full Text] [Related]
20. Metabolic effects of antiangiogenic drugs in tumors: therapeutic implications.
Quintieri L; Selmy M; Indraccolo S
Biochem Pharmacol; 2014 May; 89(2):162-70. PubMed ID: 24607274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]